Search filters

List of works by Monika Schlögelhofer

Affect recognition and functioning in putatively prodromal individuals.

scientific article published on 9 May 2013

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

scientific article published on 11 March 2020

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

scientific article published on 10 July 2019

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

scientific article published on 10 June 2020

Effect of omega-3 fatty acids for indicated prevention of young patients at risk for psychosis: when do they begin to be effective?

scientific article published on 15 June 2013

Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders: The NEURAPRO Randomized Clinical Trial.

scientific article

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

scientific article published on 16 February 2014

Emotion recognition in individuals at clinical high-risk for schizophrenia.

scientific article

F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS.

scientific article published in April 2018

Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls

scientific article published in June 2012

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations

scientific article

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

scientific article published on 16 August 2015

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

scientific article published on 14 December 2018

O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL.

scientific article

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

scientific article published on 06 September 2020

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

scientific article

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

scientific article

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

scientific article published on 6 June 2019

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

scientific article published on 09 October 2019

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

scientific article

The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis

scientific article published on 18 September 2019

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

scientific article published on 21 November 2019

Paulina is supported by:

About Paulina

Help